Feasibility Study of a Community Pilot Project for the Prevention of Alzheimer's Disease: the KetoHome Study.
NCT ID: NCT05642052
Last Updated: 2024-05-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
25 participants
INTERVENTIONAL
2022-11-28
2024-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
KNA Proof-of-Concept
NCT04968041
Community-based Brain Health Program to Address Dementia Risk
NCT05529706
nuTritiOn and deMentia AT hOme (TOMATO)
NCT05866094
Preventing and Managing Cognitive Impairment
NCT05471141
Mortality Risk Prediction Tool in Hospitalized Dementia Patients
NCT05371782
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
There are several ways to increase ketones in our body such as certain dietary oils, natural health products, physical activity or certain diets. Reducing the amount of sugar in our diet is also a strategy that can increase ketones. A low-sugar diet is already widely used in the prevention of several important diseases, including type 2 diabetes and even Alzheimer's disease.
This study will assess the feasibility of a community intervention project in a seniors' residence with the eventual overall objective of slowing the progression or onset of AD and related health indicators, through a dietary modification.
This feasibility study will last 6 months. The basic characteristics of interested participants will be collected. The global spheres of evaluation are the following: metabolic profile, cognition, quality of life and nutritional status. Glucose measurements will be taken continuously via a sensor over two weeks during the project.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
10 days control diet
Participants stay on their regular diet while glucose is continuously monitored, heart rate and number of steps is measured for 10 days.
Regular diet
Regular diet
10 days low carb diet
Participants will eat a low carb diet while glucose is continuously monitored, heart rate and number of steps is measured for 10 days.
low carb diet
low carb meals will be 50% less carbs than the regular meals
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
low carb diet
low carb meals will be 50% less carbs than the regular meals
Regular diet
Regular diet
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand, read and write French or English;
* Possess sufficient visual and auditory acuity to pass the cognitive tests.
Exclusion Criteria
* Body mass index \< 22
* Malnutrition.
* High risk of hypoglycaemia
* Moderate to severe digestive diseases that can be aggravated by dietary changes
* Severe dysphagia
* Supplementation with MCT oil, ketone salts, ketone ester, adherence to the ketogenic diet, intermittent fasting, or other diet or supplements that may significantly increase ketones;
* Participation in other intervention research projects on nutrition or aimed at metabolic change simultaneously.
60 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nestlé Health Science
INDUSTRY
Université de Sherbrooke
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rearsh Centre on Aging
Sherbrooke, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-4327
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.